Sequential pulmonary functions in survivors of leptospirosis pulmonary haemorrhage syndrome: a prospective cohort study
2024

Lung Function Recovery in Leptospirosis Survivors

Sample size: 21 publication 10 minutes Evidence: moderate

Author Information

Author(s): Priyankara Dilshan, Ruwanpathirana Pramith, Rambukwella Roshan, Perera Nilanka

Primary Institution: National Hospital of Sri Lanka

Hypothesis

What are the long-term pulmonary functions and functional limitations in survivors of Leptospirosis Pulmonary Haemorrhage Syndrome?

Conclusion

Most survivors of LPHS showed significant improvement in lung function within the first week, but many did not achieve normal lung function by 28 days.

Supporting Evidence

  • Seventeen patients (81%) had reduced FEV1 and FVC on discharge, indicating restrictive lung abnormality.
  • FVC and FEV1 improved significantly during the first 7 days after discharge.
  • Only 33.3% of patients achieved normal FVC by day 28, while 90.5% achieved normal FEV1.

Takeaway

People who survive a serious lung infection called leptospirosis can breathe better after a week, but some still have trouble after a month.

Methodology

A prospective cohort study measuring lung function at discharge, 7 days, and 28 days post-discharge using spirometry.

Potential Biases

Potential bias due to the exclusion of patients with pre-existing chronic pulmonary diseases.

Limitations

The study lacked baseline lung function parameters and did not follow up beyond 28 days.

Participant Demographics

Mean age of 44 years, predominantly male (90.5%).

Statistical Information

P-Value

p<0.001 for FEV1 improvement, p=0.008 for FVC improvement.

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/s41182-024-00665-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication